Single domain antibodies: comparison of camel VH and camelised human VH domains

The antigen binding sites of conventional antibodies are formed primarily by the hypervariable loops from both the heavy and the light chain variable domains. Functional antigen binding sites can however also be formed by heavy chain variable domains (VH) alone. In vivo, such binding sites have evol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of immunological methods 1999-12, Vol.231 (1), p.25-38
Hauptverfasser: Riechmann, Lutz, Muyldermans, Serge
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 38
container_issue 1
container_start_page 25
container_title Journal of immunological methods
container_volume 231
creator Riechmann, Lutz
Muyldermans, Serge
description The antigen binding sites of conventional antibodies are formed primarily by the hypervariable loops from both the heavy and the light chain variable domains. Functional antigen binding sites can however also be formed by heavy chain variable domains (VH) alone. In vivo, such binding sites have evolved in camels and camelids as part of antibodies, which consist only of two heavy chains and lack light chains. Analysis of the differences in amino acid sequence between the VHs of these camel heavy chain-only antibodies and VH domains from conventional human antibodies helped to design an altered human VH domain. This camelised VH proved, like the camel VH, to be a small, robust and efficient recognition unit formed by a single immunoglobulin (Ig) domain. Biochemical, structural and antigen binding characterisation properties of both camel VH domains and camelised human VH domains suggest that these can compete successfully with single chain variable domain (Fv) fragments from conventional antibodies in many applications. Of special importance in this respect is the use of such VH domains as enzyme inhibitors, for which they seem to be better suited than Fv fragments. This function appears to be closely related to their often very long third hypervariable loop, which is central for antigen recognition in their binding sites.
doi_str_mv 10.1016/S0022-1759(99)00138-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69415712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022175999001386</els_id><sourcerecordid>69415712</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-34b06c9ae9b0c84d1ff788aff3b570c53beb0bc69a9dfe5beabef7343c1b8ea53</originalsourceid><addsrcrecordid>eNqFkF1LwzAUhoMobk5_gtIr0Ytq0jRt443I8AsGu5h6G_JxopG2mUkn-O_t1iHe7erlHJ5zXngQOiX4imBSXC8wzrKUlIxfcH6JMaFVWuyhManKLC05Zvto_IeM0FGMn7incIEP0aiPvOIZG6P5wrXvNSTGN9K1iWw7p7xxEG8S7ZulDC76NvE20bKBOnl76hEzDC6CST5WjWzX6-FBPEYHVtYRTrY5Qa8P9y_Tp3Q2f3ye3s1SnbOqS2mucKG5BK6wrnJDrC2rSlpLFSuxZlSBwkoXXHJjgSmQCmxJc6qJqkAyOkHnw99l8F8riJ1oXNRQ17IFv4qi4DlhJcl2gqTMc0Yx7UE2gDr4GANYsQyukeFHECzWysVGuVj7FJyLjXJR9Hdn24KVasD8uxoc98DtAEDv49tBEFE7aDUYF0B3wni3o-IXPNuRLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17445303</pqid></control><display><type>article</type><title>Single domain antibodies: comparison of camel VH and camelised human VH domains</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Riechmann, Lutz ; Muyldermans, Serge</creator><creatorcontrib>Riechmann, Lutz ; Muyldermans, Serge</creatorcontrib><description>The antigen binding sites of conventional antibodies are formed primarily by the hypervariable loops from both the heavy and the light chain variable domains. Functional antigen binding sites can however also be formed by heavy chain variable domains (VH) alone. In vivo, such binding sites have evolved in camels and camelids as part of antibodies, which consist only of two heavy chains and lack light chains. Analysis of the differences in amino acid sequence between the VHs of these camel heavy chain-only antibodies and VH domains from conventional human antibodies helped to design an altered human VH domain. This camelised VH proved, like the camel VH, to be a small, robust and efficient recognition unit formed by a single immunoglobulin (Ig) domain. Biochemical, structural and antigen binding characterisation properties of both camel VH domains and camelised human VH domains suggest that these can compete successfully with single chain variable domain (Fv) fragments from conventional antibodies in many applications. Of special importance in this respect is the use of such VH domains as enzyme inhibitors, for which they seem to be better suited than Fv fragments. This function appears to be closely related to their often very long third hypervariable loop, which is central for antigen recognition in their binding sites.</description><identifier>ISSN: 0022-1759</identifier><identifier>EISSN: 1872-7905</identifier><identifier>DOI: 10.1016/S0022-1759(99)00138-6</identifier><identifier>PMID: 10648925</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Amino Acid Sequence ; Animals ; Antibody engineering ; Camel ; Camelus ; Heavy chain ; Humans ; Immunoglobulin ; Immunoglobulin Heavy Chains - biosynthesis ; Immunoglobulin Heavy Chains - chemistry ; Immunoglobulin Heavy Chains - genetics ; Immunoglobulin Heavy Chains - immunology ; Immunoglobulin Variable Region - biosynthesis ; Immunoglobulin Variable Region - chemistry ; Immunoglobulin Variable Region - genetics ; Immunoglobulin Variable Region - immunology ; Molecular Sequence Data ; Recombinant Proteins - biosynthesis ; Recombinant Proteins - chemistry ; Recombinant Proteins - genetics ; Recombinant Proteins - immunology ; Single domain</subject><ispartof>Journal of immunological methods, 1999-12, Vol.231 (1), p.25-38</ispartof><rights>1999 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-34b06c9ae9b0c84d1ff788aff3b570c53beb0bc69a9dfe5beabef7343c1b8ea53</citedby><cites>FETCH-LOGICAL-c458t-34b06c9ae9b0c84d1ff788aff3b570c53beb0bc69a9dfe5beabef7343c1b8ea53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0022-1759(99)00138-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10648925$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Riechmann, Lutz</creatorcontrib><creatorcontrib>Muyldermans, Serge</creatorcontrib><title>Single domain antibodies: comparison of camel VH and camelised human VH domains</title><title>Journal of immunological methods</title><addtitle>J Immunol Methods</addtitle><description>The antigen binding sites of conventional antibodies are formed primarily by the hypervariable loops from both the heavy and the light chain variable domains. Functional antigen binding sites can however also be formed by heavy chain variable domains (VH) alone. In vivo, such binding sites have evolved in camels and camelids as part of antibodies, which consist only of two heavy chains and lack light chains. Analysis of the differences in amino acid sequence between the VHs of these camel heavy chain-only antibodies and VH domains from conventional human antibodies helped to design an altered human VH domain. This camelised VH proved, like the camel VH, to be a small, robust and efficient recognition unit formed by a single immunoglobulin (Ig) domain. Biochemical, structural and antigen binding characterisation properties of both camel VH domains and camelised human VH domains suggest that these can compete successfully with single chain variable domain (Fv) fragments from conventional antibodies in many applications. Of special importance in this respect is the use of such VH domains as enzyme inhibitors, for which they seem to be better suited than Fv fragments. This function appears to be closely related to their often very long third hypervariable loop, which is central for antigen recognition in their binding sites.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibody engineering</subject><subject>Camel</subject><subject>Camelus</subject><subject>Heavy chain</subject><subject>Humans</subject><subject>Immunoglobulin</subject><subject>Immunoglobulin Heavy Chains - biosynthesis</subject><subject>Immunoglobulin Heavy Chains - chemistry</subject><subject>Immunoglobulin Heavy Chains - genetics</subject><subject>Immunoglobulin Heavy Chains - immunology</subject><subject>Immunoglobulin Variable Region - biosynthesis</subject><subject>Immunoglobulin Variable Region - chemistry</subject><subject>Immunoglobulin Variable Region - genetics</subject><subject>Immunoglobulin Variable Region - immunology</subject><subject>Molecular Sequence Data</subject><subject>Recombinant Proteins - biosynthesis</subject><subject>Recombinant Proteins - chemistry</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - immunology</subject><subject>Single domain</subject><issn>0022-1759</issn><issn>1872-7905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1LwzAUhoMobk5_gtIr0Ytq0jRt443I8AsGu5h6G_JxopG2mUkn-O_t1iHe7erlHJ5zXngQOiX4imBSXC8wzrKUlIxfcH6JMaFVWuyhManKLC05Zvto_IeM0FGMn7incIEP0aiPvOIZG6P5wrXvNSTGN9K1iWw7p7xxEG8S7ZulDC76NvE20bKBOnl76hEzDC6CST5WjWzX6-FBPEYHVtYRTrY5Qa8P9y_Tp3Q2f3ye3s1SnbOqS2mucKG5BK6wrnJDrC2rSlpLFSuxZlSBwkoXXHJjgSmQCmxJc6qJqkAyOkHnw99l8F8riJ1oXNRQ17IFv4qi4DlhJcl2gqTMc0Yx7UE2gDr4GANYsQyukeFHECzWysVGuVj7FJyLjXJR9Hdn24KVasD8uxoc98DtAEDv49tBEFE7aDUYF0B3wni3o-IXPNuRLQ</recordid><startdate>19991210</startdate><enddate>19991210</enddate><creator>Riechmann, Lutz</creator><creator>Muyldermans, Serge</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19991210</creationdate><title>Single domain antibodies: comparison of camel VH and camelised human VH domains</title><author>Riechmann, Lutz ; Muyldermans, Serge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-34b06c9ae9b0c84d1ff788aff3b570c53beb0bc69a9dfe5beabef7343c1b8ea53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibody engineering</topic><topic>Camel</topic><topic>Camelus</topic><topic>Heavy chain</topic><topic>Humans</topic><topic>Immunoglobulin</topic><topic>Immunoglobulin Heavy Chains - biosynthesis</topic><topic>Immunoglobulin Heavy Chains - chemistry</topic><topic>Immunoglobulin Heavy Chains - genetics</topic><topic>Immunoglobulin Heavy Chains - immunology</topic><topic>Immunoglobulin Variable Region - biosynthesis</topic><topic>Immunoglobulin Variable Region - chemistry</topic><topic>Immunoglobulin Variable Region - genetics</topic><topic>Immunoglobulin Variable Region - immunology</topic><topic>Molecular Sequence Data</topic><topic>Recombinant Proteins - biosynthesis</topic><topic>Recombinant Proteins - chemistry</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - immunology</topic><topic>Single domain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riechmann, Lutz</creatorcontrib><creatorcontrib>Muyldermans, Serge</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of immunological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riechmann, Lutz</au><au>Muyldermans, Serge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Single domain antibodies: comparison of camel VH and camelised human VH domains</atitle><jtitle>Journal of immunological methods</jtitle><addtitle>J Immunol Methods</addtitle><date>1999-12-10</date><risdate>1999</risdate><volume>231</volume><issue>1</issue><spage>25</spage><epage>38</epage><pages>25-38</pages><issn>0022-1759</issn><eissn>1872-7905</eissn><abstract>The antigen binding sites of conventional antibodies are formed primarily by the hypervariable loops from both the heavy and the light chain variable domains. Functional antigen binding sites can however also be formed by heavy chain variable domains (VH) alone. In vivo, such binding sites have evolved in camels and camelids as part of antibodies, which consist only of two heavy chains and lack light chains. Analysis of the differences in amino acid sequence between the VHs of these camel heavy chain-only antibodies and VH domains from conventional human antibodies helped to design an altered human VH domain. This camelised VH proved, like the camel VH, to be a small, robust and efficient recognition unit formed by a single immunoglobulin (Ig) domain. Biochemical, structural and antigen binding characterisation properties of both camel VH domains and camelised human VH domains suggest that these can compete successfully with single chain variable domain (Fv) fragments from conventional antibodies in many applications. Of special importance in this respect is the use of such VH domains as enzyme inhibitors, for which they seem to be better suited than Fv fragments. This function appears to be closely related to their often very long third hypervariable loop, which is central for antigen recognition in their binding sites.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>10648925</pmid><doi>10.1016/S0022-1759(99)00138-6</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1759
ispartof Journal of immunological methods, 1999-12, Vol.231 (1), p.25-38
issn 0022-1759
1872-7905
language eng
recordid cdi_proquest_miscellaneous_69415712
source MEDLINE; Elsevier ScienceDirect Journals
subjects Amino Acid Sequence
Animals
Antibody engineering
Camel
Camelus
Heavy chain
Humans
Immunoglobulin
Immunoglobulin Heavy Chains - biosynthesis
Immunoglobulin Heavy Chains - chemistry
Immunoglobulin Heavy Chains - genetics
Immunoglobulin Heavy Chains - immunology
Immunoglobulin Variable Region - biosynthesis
Immunoglobulin Variable Region - chemistry
Immunoglobulin Variable Region - genetics
Immunoglobulin Variable Region - immunology
Molecular Sequence Data
Recombinant Proteins - biosynthesis
Recombinant Proteins - chemistry
Recombinant Proteins - genetics
Recombinant Proteins - immunology
Single domain
title Single domain antibodies: comparison of camel VH and camelised human VH domains
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T03%3A26%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Single%20domain%20antibodies:%20comparison%20of%20camel%20VH%20and%20camelised%20human%20VH%20domains&rft.jtitle=Journal%20of%20immunological%20methods&rft.au=Riechmann,%20Lutz&rft.date=1999-12-10&rft.volume=231&rft.issue=1&rft.spage=25&rft.epage=38&rft.pages=25-38&rft.issn=0022-1759&rft.eissn=1872-7905&rft_id=info:doi/10.1016/S0022-1759(99)00138-6&rft_dat=%3Cproquest_cross%3E69415712%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17445303&rft_id=info:pmid/10648925&rft_els_id=S0022175999001386&rfr_iscdi=true